Elisabeth Stampa, Medicines for Europe president

As win­ter ap­proach­es, a Eu­ro­pean gener­ics group rais­es alarm over en­er­gy prices for man­u­fac­tur­ers

While cold­er tem­per­a­tures are fast ap­proach­ing, the sit­u­a­tion sur­round­ing the rise of en­er­gy prices in Eu­rope is hit­ting busi­ness­es of every kind, in­clud­ing gener­ic drug man­u­fac­tur­ers.

Med­i­cines for Eu­rope, a group that rep­re­sents the gener­ic in­dus­try on the con­ti­nent, sent a let­ter ad­dressed to en­er­gy min­is­ters and com­mis­sion­ers con­cern­ing in­fla­tion and the costs of en­er­gy on the sup­ply of gener­ic med­i­cines.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.